These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6117378)

  • 1. Demonstration of training effect during chronic beta-adrenergic blockade in patients with coronary artery disease.
    Pratt CM; Welton DE; Squires WG; Kirby TE; Hartung GM; Miller RR
    Circulation; 1981 Dec; 64(6):1125-9. PubMed ID: 6117378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of exercise training in patients with coronary artery disease who are taking propranolol.
    Laslett LJ; Paumer L; Scott-Baier P; Amsterdam EA
    Circulation; 1983 Nov; 68(5):1029-34. PubMed ID: 6616786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does exercise alter anaerobic threshold in coronary artery disease during beta blockade?
    Koyal SN; Stuart RJ; Lundstrom R; Thomas V; Ellestad MH
    Br J Sports Med; 1985 Jun; 19(2):107-11. PubMed ID: 4027493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic blockade and training in healthy men--effects on central circulation.
    Svedenhag J; Henriksson J; Juhlin-Dannfelt A; Asano K
    Acta Physiol Scand; 1984 Jan; 120(1):77-86. PubMed ID: 6144241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease.
    Kern MJ; Ganz P; Horowitz JD; Gaspar J; Barry WH; Lorell BH; Grossman W; Mudge GH
    Circulation; 1983 Jun; 67(6):1178-85. PubMed ID: 6133636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
    Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered adaptive responses to training by nonselective beta-adrenergic blockade in coronary artery disease.
    Ehsani AA
    Am J Cardiol; 1986 Aug; 58(3):220-4. PubMed ID: 2874736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise training during chronic beta blockade in cardiovascular disease.
    Fletcher GF
    Am J Cardiol; 1985 Apr; 55(10):110D-113D. PubMed ID: 2859788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of propranolol on postexercise left ventricular ejection time index.
    Boudoulas H; Ruff PD; Fulkerson PK; Lewis RP; Dervenagas S
    Am J Cardiol; 1981 Aug; 48(2):357-60. PubMed ID: 7270443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Frank-Starling mechanism in maintaining cardiac output during increasing levels of treadmill exercise in beta-blocked normal men.
    Bevilacqua M; Savonitto S; Bosisio E; Chebat E; Bertora PL; Sardina M; Norbiato G
    Am J Cardiol; 1989 Apr; 63(12):853-7. PubMed ID: 2564724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
    Subramanian VB; Bowles MJ; Davies AB; Raftery EB
    Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
    Prida XE; Feldman RL; Hill JA; Pepine CJ
    Am J Cardiol; 1987 Aug; 60(4):244-8. PubMed ID: 2887101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antianginal effects of corwin, a new beta-adrenoceptor partial agonist.
    Detry JM; Decoster PM; Buy JJ; Rousseau MF; Brasseur LA
    Am J Cardiol; 1984 Feb; 53(4):439-43. PubMed ID: 6141726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women.
    Gullestad L; Hallen J; Medbø JI; Grønnerød O; Holme I; Sejersted OM
    Br J Clin Pharmacol; 1996 Jan; 41(1):57-67. PubMed ID: 8824694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha- and beta-blockade in angina pectoris.
    Taylor SH
    Drugs; 1984; 28 Suppl 2():69-87. PubMed ID: 6151892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta-blockers on the relation between QT-interval and heart rate in exercise ECG.
    Algra A; Roelandt JR; Tijssen JG; Simoons ML; Pool J
    Eur Heart J; 1987 Aug; 8 Suppl D():71-3. PubMed ID: 2890523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessment of failed beta-blocker treatment in angina pectoris by peak-exercise heart rate measurements.
    Jackson G; Atkinson L; Oram S
    Br Med J; 1975 Sep; 3(5984):616-8. PubMed ID: 240479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of beta-adrenergic blockade.
    Aström H
    Br Heart J; 1968 Jan; 30(1):44-9. PubMed ID: 5637556
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-blocking drugs for arrhythmias, hypertension, and ischemic heart disease.
    Johns VJ
    Am J Surg; 1984 Jun; 147(6):725-30. PubMed ID: 6145367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of propranolol on myocardial perfusion images and exercise ejection fraction in men with coronary artery disease.
    Rainwater J; Steele P; Kirch D; LeFree M; Jensen D; Vogel R
    Circulation; 1982 Jan; 65(1):77-81. PubMed ID: 7053291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.